Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-08 10:18 am Sale | 2023-12-29 | 13G | Syndax Pharmaceuticals, Inc. SNDX | Wellington Management Group LLP | 7,585,221 8.940% | -398,221 (-4.99%) | Filing History |
| 2024-01-25 4:59 pm Purchase | 2023-12-31 | 13G | Syndax Pharmaceuticals, Inc. SNDX | BlackRock Inc. BLK | 7,015,548 8.300% | 2,663,516 (+61.20%) | Filing History |
| 2024-01-25 11:20 am Purchase | 2023-12-31 | 13G | Syndax Pharmaceuticals, Inc. SNDX | STATE STREET CORP STT | 5,016,224 5.910% | 1,367,761 (+37.49%) | Filing History |
| 2023-10-31 4:26 pm Purchase | 2023-10-30 | 13G | Syndax Pharmaceuticals, Inc. SNDX | Point72 Asset Management, L.P. | 3,520,402 5.100% | 3,520,402 (New Position) | Filing History |
| 2023-10-05 12:23 pm Sale | 2023-10-03 | 13G | Syndax Pharmaceuticals, Inc. SNDX | Frazier Life Sciences Public Fund, L.P. | 0 0.000% | -3,708,838 (Position Closed) | Filing History |
| 2023-02-14 4:46 pm Sale | 2022-12-31 | 13G | Syndax Pharmaceuticals, Inc. SNDX | Nantahala Capital Management, LLC | 975,705 1.400% | -2,074,854 (-68.02%) | Filing History |
| 2023-02-14 3:47 pm Purchase | 2022-12-31 | 13G | Syndax Pharmaceuticals, Inc. SNDX | Avidity Partners Management LP | 6,718,142 9.700% | 1,474,123 (+28.11%) | Filing History |
| 2023-02-14 12:12 pm Purchase | 2022-12-31 | 13G | Syndax Pharmaceuticals, Inc. SNDX | Frazier Life Sciences Public Fund, L.P. | 3,708,838 5.400% | 936,776 (+33.79%) | Filing History |
| 2023-02-14 11:53 am Sale | 2022-12-31 | 13G | Syndax Pharmaceuticals, Inc. SNDX | BIOTECHNOLOGY VALUE FUND L P | 1,451,197 2.100% | -3,480,682 (-70.58%) | Filing History |
| 2023-02-06 2:46 pm Purchase | 2022-12-31 | 13G | Syndax Pharmaceuticals, Inc. SNDX | STATE STREET CORP STT | 3,648,463 5.360% | 3,648,463 (New Position) | Filing History |
| 2023-01-31 5:52 pm Purchase | 2022-12-31 | 13G | Syndax Pharmaceuticals, Inc. SNDX | BlackRock Inc. BLK | 4,352,032 6.400% | 662,138 (+17.94%) | Filing History |
| 2023-01-10 09:23 am Purchase | 2022-12-30 | 13G | Syndax Pharmaceuticals, Inc. SNDX | Wellington Management Group LLP | 7,983,442 11.720% | 6,384,676 (+399.35%) | Filing History |
| 2022-03-04 5:02 pm Sale | 2022-02-25 | 13D | Syndax Pharmaceuticals, Inc. SNDX | Access Industries Holdings LLC | 2,603,709 4.700% | -78,678 (-2.93%) | Filing History |
| 2022-02-14 1:12 pm Purchase | 2021-12-31 | 13G | Syndax Pharmaceuticals, Inc. SNDX | BIOTECHNOLOGY VALUE FUND L P | 4,931,879 8.900% | 1,221,190 (+32.91%) | Filing History |
| 2022-02-14 08:34 am Purchase | 2021-12-31 | 13G | Syndax Pharmaceuticals, Inc. SNDX | Nantahala Capital Management, LLC | 3,050,559 5.800% | 3,050,559 (New Position) | Filing History |
| 2022-02-11 8:54 pm Purchase | 2021-12-31 | 13G | Syndax Pharmaceuticals, Inc. SNDX | Avidity Partners Management LP | 5,244,019 9.900% | 494,019 (+10.40%) | Filing History |
| 2022-02-10 10:49 am Sale | 2021-12-31 | 13G | Syndax Pharmaceuticals, Inc. SNDX | ADAGE CAPITAL PARTNERS GP L.L.C. | 1,200,000 2.280% | -1,500,000 (-55.56%) | Filing History |
| 2022-02-07 4:41 pm Purchase | 2021-12-31 | 13G | Syndax Pharmaceuticals, Inc. SNDX | BlackRock Inc. BLK | 3,689,894 7.000% | 1,369,488 (+59.02%) | Filing History |
| 2022-02-04 09:24 am Sale | 2021-12-31 | 13G | Syndax Pharmaceuticals, Inc. SNDX | Wellington Management Group LLP | 1,598,766 3.040% | -1,016,677 (-38.87%) | Filing History |
| 2021-12-23 5:28 pm Purchase | 2021-12-20 | 13G | Syndax Pharmaceuticals, Inc. SNDX | Frazier Life Sciences Public Fund, L.P. | 2,772,062 5.600% | 2,772,062 (New Position) | Filing History |